Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin

被引：33

作者：

David, Miruna D. ^{[1
,2
]}

Gill, Martin J. ^{[2
]}

机构：

[1] Walsgrave Gen Hosp, Warwickshire NHS Trust, Coventry CV2 2DX, W Midlands, England

[2] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Dept Microbiol, Birmingham B15 2TH, W Midlands, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 04期

关键词：

D O I：

10.1093/jac/dkn009

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：962 / 964

页数：4

共 6 条

[1]

*ANT REF LAB ANT A, 2007, GUID US

[2] Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa [J].

Bergen, Phillip J. ;

Li, Jian ;

Rayner, Craig R. ;

Nation, Roger L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :1953-1958

[3]

[British Medical Association Royal Pharmaceutical Society of Great Britain], 2007, BRIT NAT FORM

[4] Toxicity of polymyxins: a systematic review of the evidence from old and recent studies [J].

Falagas, Matthew E. ;

Kasiakou, Sofia K. .

CRITICAL CARE, 2006, 10 (01)

[5] Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].

Falagas, ME ;

Kasiakou, SK .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341

[6] Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections [J].

Li, Jian ;

Nation, Roger L. ;

Turnidge, John D. ;

Milne, Robert W. ;

Coulthard, Kingsley ;

Rayner, Craig R. ;

Paterson, David L. .

LANCET INFECTIOUS DISEASES, 2006, 6 (09) :589-601

← 1 →